The Enterprise Value as of September 2024 (TTM) for NuCana plc (NCNA) is -5425771.22

According to NuCana plc’s latest financial reports and current stock price. The company's current Enterprise Value is -5425771.22. This represents a change of 515.31% compared to the average of -881797.99 of the last 4 quarters.

NuCana plc (NCNA) Historical Enterprise Value (quarterly & annually)

How has NCNA Enterprise Value performed in the past?

The mean historical Enterprise Value of NuCana plc over the last ten years is 156.90M. The current -5425771.22 Enterprise Value has changed -445.81% with respect to the historical average. Over the past ten years (40 quarters), NCNA's Enterprise Value was at its highest in in the September 2018 quarter at 476.69M. The Enterprise Value was at its lowest in in the June 2022 quarter at -15502637.63.

NuCana plc (NCNA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NuCana plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NuCana plc (NCNA) Average Enterprise Value

How has NCNA Enterprise Value performed in the past?

The current Enterprise Value of NuCana plc (NCNA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NuCana plc (NCNA) Enterprise Value vs. Peers

How is NCNA’s Enterprise Value compared to its peers?

NuCana plc’s Enterprise Value is less than eFFECTOR Therapeutics, Inc. (0), less than Virios Therapeutics, Inc. (3.85M), less than Zura Bio Limited (2.58M), less than Navidea Biopharmaceuticals, Inc. (85.79M), less than ZyVersa Therapeutics, Inc. (-2504975.00), less than Cidara Therapeutics, Inc. (2.32M), greater than Silence Therapeutics plc (-77580827.00), less than Applied Therapeutics, Inc. (536.04M), less than CytomX Therapeutics, Inc. (796.79M), less than Rani Therapeutics Holdings, Inc. (59.90M), less than Vincerx Pharma, Inc. (0), less than Tenaya Therapeutics, Inc. (153.60M), less than Corvus Pharmaceuticals, Inc. (15.52M), less than ALX Oncology Holdings Inc. (130.21M), less than Mereo BioPharma Group plc (336.77M), less than Acumen Pharmaceuticals, Inc. (116.24M), less than Day One Biopharmaceuticals, Inc. (534.74M), less than Inozyme Pharma, Inc. (115.26M), less than Galera Therapeutics, Inc. (1.02B), less than null (394.08M), less than null (-5258016.00),

Build a custom stock screener for NuCana plc (NCNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NuCana plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NuCana plc (NCNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NuCana plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.